Drug Discover and Development

The  Biomarkers have incredible potential to affect rate of success of clinical trials and identify new drug targets and advance diagnostic assays for early detection of disease. Biomarker development originates in the drug discovery phase and leads to clinical validation stage. In the target, discovery and validation stage biomarkers are used to identify and justify targets for therapy.

Biomarkers should have consistent characteristics with an acceptable sensitivity and specificity representing a specific toxicity or therapeutic effect of the drug, a specific physiological response to a treatment, a pathological progression, or a physiological factor.

·         Translational Biomarkers

·         Biomarkers discovery

·         Biomarkers clinical validation


Are you interested in

Mail us at

Program Enquiry
biomarkers@molecularbiologyconference.com
Sponsorship/Exhibitor/Advertising
biomarkers@molecularbiologyconference.com
General Queries
biomarkers@molecularbiologyconference.com
More details about sponsorship:sponsors@alliedacademies.com
Copyright © 2018-2019 Allied Academies, All Rights Reserved.